Surgery News and Research

RSS

Vaginal reconstruction not needed for most inter-sex females

Dispelling a common myth, researchers from the Johns Hopkins Children's Center say vaginal reconstruction should be a matter of preference for most teens or adult women born with a type of inter-sex condition marked by the presence of both female and male genitals.

28 Oct 2007

Removal of uterus increases risk of urinary incontinence

Researchers at the Swedish medical university Karolinska Institutet have shown that hysterectomy – a common operation involving the removal of the uterus – greatly increases the risk of urinary incontinence.

28 Oct 2007

PET scans track small tumors after stereotactic body radiotherapy

Readily available CT screening for lung cancer is increasing the discovery of small, primary lung cancers.

28 Oct 2007

Surgery, radiation gives early survival advantage in bile duct cancer

Oregon Health & Science University researchers are reporting the discovery of an early survival advantage when a combination of surgery and radiation therapy is used for patients with a rare but deadly bile duct cancer.

28 Oct 2007

Advancement in radiation oncology treatment called IMRT improves care, avoids healthy tissue

New advancements in a radiation oncology treatment called IMRT (intensity modulated radiation therapy) are proving far superior to standard radiation procedures used today in safeguarding the healthy tissues surrounding cancerous tumors, and thus improving patient care.

28 Oct 2007

Men with bladder exstrophy report robust sex lives, but women fare worse

Adult men born with a severe urological anomaly in which the bladder forms outside of the abdomen report much more robust sexual lives than women born with the same condition, according to a small study led by urologists at the Johns Hopkins Children's Center.

28 Oct 2007

Many are interested in having cosmetic surgery

Forty-eight percent of women surveyed said they would be interested in cosmetic surgery, liposuction or both, and another 23 percent said they would possibly be interested.

28 Oct 2007

FDA issues communication on ongoing safety review of Aprotinin injection

Last week, FDA was notified that a Canadian research group stopped a study on Trasylol because the drug appeared to increase the risk for death compared to the other antifibrinolytic drugs used in the study. Antifibrinolytic drugs help slow the breakdown of blood clots and subsequent excessive bleeding.

28 Oct 2007

Extensive review supports safety of silicone breast implants

An exhaustive review - the first in almost a decade, including the latest evidence on the health effects of silicone breast implants - finds no increase in the risk of cancers, connective tissue diseases, or other serious chronic diseases.

28 Oct 2007

Emerging cancer therapies and novel targets

What are the cancer drugs of tomorrow and how will they be developed? At the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, researchers will present some answers to these and other pressing questions regarding emerging cancer therapeutics.

25 Oct 2007

New insight into how memory is wired in the human brain

Recognizing someone's name but forgetting how you met them is all in your head

25 Oct 2007

Lower frequency deep brain stimulation effective treatment for dystonia

A Mount Sinai Medical Center study has found that lower frequency deep brain stimulation in young patients with primary torsion dystonia is as effective as higher frequency stimulation, which has been commonly used.

25 Oct 2007

Recent colds influence adverse respiratory events after surgery in children

For children undergoing general anesthesia for surgery or other procedures, the risks of several adverse respiratory (breathing-related) events are greater if the child has recently had a cold or other upper respiratory infection (URI).

24 Oct 2007

Simple blood test may accurately detect thoracic aneurysm disease

Yale scientists have discovered a way to use a simple blood test that may accurately detect thoracic aneurysm disease (TAA), which gives little warning and is almost always fatal if untreated.

24 Oct 2007

75% of hospital patients suffer from malnutrition regardless of their pathology

A study of 817 patients conducted in the Department of Nutrition and Bromatology at the University of Granada (UGR), in collaboration with the Unit of Nutrition and Dietetics at the hospital Virgen de las Nieves (Granada, Spain) of 817 patients, showed that 75% of hospitalised patients suffer from malnutrition regardless of their pathology.

24 Oct 2007

Charcot foot becoming more common

Charcot foot is a sudden softening of the foot's bones caused by severe neuropathy, or nerve damage, a common diabetic foot complication. It can trigger an avalanche of problems, including joint loss, fractures, collapse of the arch, massive deformity, ulcers, amputation, and even death. As the disorder progresses, the bottom of the foot can become convex, bulging like the hull of a ship.

24 Oct 2007

Review of percutaneous valve therapy

Researchers at TCT 2007, the annual scientific symposium of the Cardiovascular Research Foundation (CRF), will present new studies evaluating a rapidly advancing field within interventional cardiology: percutaneous procedures to repair and replace defective heart valves.

24 Oct 2007

Researchers pinpoint brain waves that distinguish false memories from real ones

For the first time, researchers at the University of Pennsylvania are able to pinpoint brain waves that distinguish true from false memories, providing a better understanding of how memory works and creating a new strategy to help epilepsy patients retain cognitive function.

24 Oct 2007

Incisionless surgery for acid reflux disease

Surgeons at the Ohio State University Medical Center have performed the first incisionless operations in the United States using a device recently approved by the Food and Drug Administration to stop gastroesophageal reflux disease.

24 Oct 2007

SPIRIT III trial shows fewer major adverse cardiac events

Late breaking results from the SPIRIT III trial, presented at TCT 2007, the annual scientific symposium of the Cardiovascular Research Foundation, show that after 12 months, there were significantly fewer major adverse cardiac events (MACE) such as heart attacks, deaths from cardiac causes or repeat procedures (angioplasty or surgery) to clear the original vessel blockage after using a Xience V everolimus-eluting coronary stent than a Taxus paclitaxel-eluting stent.

24 Oct 2007